Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Series B financing at Trubion to fund pipeline advancement

July 19, 2004

Active Biotech describes CD80 antagonists

July 15, 2004

Phenomix and Genentech establish collaboration for immune disorders

July 15, 2004

Caspases involved in immune thrombocytopenia

July 15, 2004

CDC recommends resumption of third Prevnar dose

July 13, 2004

Isotechnika cleared to commence U.S. phase Ib study of TAFA-93

July 12, 2004

Enrollment open in phase II Xolair peanut allergy study

July 9, 2004

MeNZB meningococcal B vaccine approved in New Zealand

July 9, 2004

trans-ISA-247 completes single ascending dose study

July 9, 2004

ZymoGenetics licenses to Novo Nordisk rights to IL-28A, IL-29 and IL-31

July 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.